AM1 theoretical study, synthesis and biological evaluation of some benzofuran analogues of anti-inflammatory arylalkanoic acids

European Journal of Pharmaceutical Sciences

Volumn 7, Issue 2, 1999, Pages 161-166

  Santana, Lourdes ^a   Teijeira, Marta ^a   Uriarte, Eugenio ^a   Teran, Carmen ^b   Liñares, Belen ^a   Villar, Rosa ^a   Laguna, Reyes ^a   Cano, Ernesto ^a  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^b UNIVERSITY OF VIGO   (Spain)

Author keywords

AM1 theoretical study; Benzofuranacetic acids; Chemical synthesis; Platelet aggregation inhibitors

Indexed keywords

ARYLALIPHATIC CARBOXYLIC ACID; BENZOFURAN 3 ACETIC ACID; BENZOFURAN 3 ACETIC ACID DERIVATIVE; BENZOFURAN DERIVATIVE; IBUPROFEN; INDOMETACIN; MALONALDEHYDE; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN SYNTHASE INHIBITOR; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG DESIGN; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; INFRARED SPECTROPHOTOMETRY; MASS SPECTROMETRY; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; QUANTUM CHEMISTRY; REACTION ANALYSIS; STRUCTURE ACTIVITY RELATION; THEORY; THROMBOCYTE;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BENZOFURANS; CYCLOOXYGENASE INHIBITORS; HUMANS; MOLECULAR CONFORMATION;

EID: 0032944624     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-0987(98)00019-0     Document Type: Article

References (11)

1. Appleton R.A., Brown K. Conformational requirements at the prostaglandin cyclooxygenase receptor site. Prostaglandins. 18:1979;29-32.
2. BIOSYM Technologies, Inc., 10065 Barnes Canyon Road, San Diego, CA 92121.
3. Deshpande A.R., Paradkar M.V. Synthesis of 3-(3-benzofuranyl) coumarins. Synth. Commun. 20:1990;809-816.
4. Dewar M.J.S., Zoebisch E.G., Healy E.F., Stewart J.J.P. AM1: A new general purpose quantum mechanical molecular model. J. Am. Chem. Soc. 107:1985;3902-3909.
5. Gund P., Shen T.Y. A model for the prostaglandin synthetase cyclooxygenase site and its inhibition by antiinflammatory arylacetic acids. J. Med. Chem. 20:1977;1146-1152.
6. Mehler E.L., Gerhards J. Interaction model for the antiinflammatory action of benzoic and salicylic acids and phenols. J. Int. Quantum Chem. 35:1989;205-209.
7. Rendu F., Marche P., Maclouf J., Girad A., Levy-Toledano S. Triphosphoinositide breakdown and dense body release as the earliest events in thrombin-induced activation of human platelets. Biochem. Biophys. Res. Commun. 116:1983;513-519.
8. Salvetti F., Buttinoni A., Cesarini R. Relationships between a hydrophobic cyclooxygenase site model and indoprofen structure. Eur. J. Med. Chem. 16:1981;81-90.
9. Smith J.B., Ingerman C.M., Silver M.J. Malondialdehyde formation as an indicator of prostaglandin production by human platelets. J. Lab. Clin. Med. 88:1976;167-172.
10. Vane J.R. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature (New Biol.). 231:1971;232-235.
11. Zagotto G., Gia O., Baccichetti F., Uriarte E., Palumbo M. Synthesis and photobiological properties of 4-hydroxymethyl-4′-methylpsoralen derivatives. Photochem. Photobiol. 58:1993;486-491.